| |
 |
|
|
|
| |
| Locations |
 |
|
| |
|
MIAMI, FL
March 15, 2010
Fleming A Taste of Denmark
8511 SW 136th Street
ATLANTA, GA
March 16, 2010
Atlanta Fish Market
265 Pharr Road, NE
HOUSTON, TX
March 17, 2010
Truluck’s Seafood, Steak and Crab House
5350 Westheimer
NEW YORK, NY
March 22, 2010
McCormick & Schmick’s
1285 Avenue of Americas
PITTSBURGH, PA
March 23, 2010
Monterey Bay Fish Grotto
1411 Grandview Avenue
|
INDIANAPOLIS, IN
March 24, 2010
Eddie Merlot’s
3645 E. 96th Street
ST. LOUIS, MO
March 25, 2010
Jim Edmonds 15 Steakhouse
1900 Locust Avenue
PHOENIX, AZ
April 19, 2010
McCormick & Schmick’s
2575 E Camelback Road
LAS VEGAS, NV
April 20, 2010
Roy’s Las Vegas
620 East Flamingo Road
LOS ANGELES, CA
April 21, 2010
Roy’s Los Angeles
800 S Figueroa St., Suite 100
|
|
| |
| Faculty |
|
|
| |
|
Marin H. Kollef, MD
Golman Professor of Medicine
Director, Medical Intensive Care Unit
Director, Respiratory
Care Services
Washington University
School of Medicine
St. Louis, Missouri
|
Yoav Golan, MD, MS
Assistant Professor of Medicine
Tufts University
School of Medicine
Division of Geographic Medicine
and Infectious Diseases
Tufts Medical Center
Boston, Massachusetts
|
|
| |
| Overview |
|
|
| |
|
Nosocomial (hospital-acquired) infections continue to complicate the clinical course of critically ill patients and, consequently, to create substantial economic and human costs. These infections may lead to complications in approximately 30% of those patients admitted to an intensive care unit (ICU) and cost an estimated $25,000 per infection. Previous studies have shown that the administration of inadequate antimicrobial treatment of nosocomial infections is associated with a significantly higher mortality rate; therefore, new guidelines and evidence-based practices to prevent healthcare-associated infections have been developed to improve patient outcomes. Although healthcare providers are cognizant of measures to control infection, inconsistent application of these measures remains a concern in the ICU and surgical settings.
In this regional dinner meeting series, we will present up-to-date information on the risk of acquiring nosocomial infections, highlight the most common sites of these infections, and discuss new guidelines for preventing and controlling infections in the hospital population. The goals are to enhance the awareness and understanding of the risks for infections and encourage guideline-based application of infection control measures to promote more favorable outcomes for patients.
|
|
| |
| Agenda |
|
|
| |
| 6:00 – 6:30 PM |
Registration and Dinner |
| 6:30 – 6:35 PM |
Introduction and Overview
Local Moderator |
| 6:35 – 7:00 PM |
Invasive Bacterial Infections:
Encouraging Guideline-Based Management
Marin H. Kollef, MD |
| 7:00 – 7:25 PM |
The Changing Epidemiology of Invasive
Candidiasis: Strategies for Early Treatment
of Candidemia and Invasive Candidiasis
Yoav Golan, MD, MS |
| 7:25 – 7:55 PM |
Question and Answer Session |
| 7:55 – 8:00 PM |
Activity Conclusion
Local Moderator
|
|
|
| |
| Learning Objectives |
|
|
| |
|
Upon the completion of this activity, the participant should be better able to:
- IDENTIFY patients at risk for infections due to yeast and multiply resistant gram-negative and gram-positive pathogens.
- EXPLAIN the rationale for early anti-Candida strategies in the ICU.
- DISCUSS issues that influence antibiotic stewardship.
- USE guidelines to optimize outcomes associated with invasive
bacterial and fungal infections.
|
|
| |
| CE Information |
|
|
| |
|
INTENDED AUDIENCE – Infectious disease physicians, hospitalists, internal
medicine physicians, critical care and intensive care physicians; infectious disease,
critical care, and ICU nurses; fellows (surgical and medical); and hospital
pharmacists, ICU pharmacists, and hospital formulary committee directors.
PHYSICIAN CONTINUING MEDICAL EDUCATION:
ACCREDITATION STATEMENT – This activity has been planned and implemented
in accordance with the Essential Areas and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint sponsorship
of Postgraduate Institute for Medicine (PIM) and ASi
M. PIM is accredited by the ACCME to provide continuing medical education
for physicians.
CREDIT DESIGNATION STATEMENT – Postgraduate Institute for
Medicine designates this educational activity for a maximum of 1.5 AMA PRA
Category 1 Credit(s)TM. Physicians should only claim credit commensurate
with the extent of their participation in the activity.
PHARMACIST CONTINUING EDUCATION:
ACCREDITATION STATEMENT – Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education.
 CREDIT DESIGNATION STATEMENT – Postgraduate Institute
for Medicine designates this continuing education activity for a maximum
of 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for
Pharmacy Education. (Universal Activity Number – 0809-9999-10-049-L01-P.)
DISCLOSURE OF CONFLICTS OF INTEREST – Postgraduate Institute for
Medicine (PIM) requires instructors, planners, managers, and other individuals
who are in a position to control the content of this activity to disclose any
real or apparent conflict of interest they may have as related to the content
of this activity. All identified conflicts of interest are thoroughly vetted by
PIM for fair balance, scientific objectivity of studies mentioned in the materials
or used as the basis for content, and appropriateness of patient care
recommendations.
AMERICANS WITH DISABILITIES ACT – Event staff will be glad to
assist you with any special needs (ie, physical, dietary, etc). Please contact
ASiM prior to the live event at 908-253-9001.
FEE INFORMATION – There is no fee for this educational activity.
TYPE OF ACTIVITY – Knowledge
LIVE RELEASE DATE – March 15, 2010
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.
|
|
| |
|
| |
|
|
|
